Author:
Stergiopoulou Dimitra,Georgoulias Vassilis,Markou Athina N.,Lianidou Evi
Reference61 articles.
1. Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began;J L Meisel;Am Soc Clin Oncol Educ Book,2018
2. PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer;P Criscitiello;Front Oncol,2021
3. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer;J O Brett;Breast Cancer Res,2021
4. PIK3CA mutation inhibition in hormone receptorpositive breast cancer: time has come;L De Mattos-Arruda;ESMO Open,2020